Venrock Healthcare Capital Partners III, L.P.
FollowFiler group, 10 members, built by the linking rules
Venrock Healthcare Capital Partners III, L.P. is a filer group of 10 members, 1 of them filing 13F reports, with 21 filings between them.
Members
Each member with the evidence that put it in the group. A member counts only inside the quarters shown (method).
| Member | Kind | Quarters | Evidence |
|---|---|---|---|
| VHCP Management III, LLCCIK 1738053 | 13F filer | from Q4 2026 |
|
| Nimish Shah | named person | from Q4 2026 |
|
| Koh Bong YCIK 1615979 | other CIK | from Q4 2026 |
|
| Shah Nimish PCIK 1698082 | other CIK | from Q4 2026 |
|
| Venrock Healthcare Capital Partners III, L.P.CIK 1738048 | other CIK | all |
|
| VHCP Co-Investment Holdings III, LLCCIK 1750761 | other CIK | from Q4 2026 |
|
| Venrock Healthcare Capital Partners EG, L.P.CIK 1808512 | other CIK | from Q4 2026 |
|
| VHCP Management EG, LLCCIK 1808518 | other CIK | from Q4 2026 |
|
| VHCP Management XP, LLCCIK 2037104 | other CIK | from Q4 2026 |
|
| Venrock Healthcare Capital Partners XP, L.P.CIK 2037157 | other CIK | from Q4 2026 |
|
Filings of the group
The union of the members' filings: 13F reports and notices, 13D and 13G naming a member, and Forms 3, 4 and 5 with a member as reporting owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13G 0001231919-26-001621 | OKUR | 2026-11-20 | ||
| 13G/A 0001738048-26-000100 | XFOR | 2026-11-16 | ||
| 13G/A 0001738048-26-000098 | VOR | 2026-11-16 | ||
| 13G/A 0001738048-26-000096 | KRRO | 2026-11-16 | ||
| 13G/A 0001738048-26-000094 | JBIO | 2026-11-16 | ||
| 13G/A 0001738048-26-000092 | HELP | 2026-11-16 | ||
| 13G/A 0001738048-26-000090 | CBIO | 2026-11-16 | ||
| 13G/A 0001738048-26-000088 | ACHV | 2026-11-16 | ||
| Form 4 0001231919-26-001536 | Lycia Therapeutics, Inc. | 2026-11-04 | ||
| 13G 0001738048-26-000079 | ENTX | 2026-10-30 | ||
| 13G 0001738048-26-000077 | LYCA | 2026-10-30 | ||
| Form 4 0001231919-26-001519 | Lycia Therapeutics, Inc. | 2026-10-30 | ||
| Form 4 0001231919-26-001503 | Lycia Therapeutics, Inc. | 2026-10-27 | ||
| 13G 0001738048-26-000075 | FLSC | 2026-10-27 | ||
| Form 3 0001231919-26-001493 | Lycia Therapeutics, Inc. | 2026-10-22 | ||
| 13F-HR 0000950123-20-001882 | Quarter ended 2019-12-31 | 2020-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-19-010838 | Quarter ended 2019-09-30 | 2019-11-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-19-007812 | Quarter ended 2019-06-30 | 2019-08-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-19-004908 | Quarter ended 2019-03-31 | 2019-05-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-19-001655 | Quarter ended 2018-12-31 | 2019-02-13 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-18-011333 | Quarter ended 2018-09-30 | 2018-11-13 | acceptance time not in the bulk data set |